MYOCARDIAL FIBROSIS
Clinical trials for MYOCARDIAL FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MYOCARDIAL FIBROSIS trials appear
Sign up with your email to follow new studies for MYOCARDIAL FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smartphone app and health coach aim to reverse heart damage from high blood pressure
Disease control Not yet recruitingThis study tests whether a 12-month digital program combining a mobile app, wearable device, and health coaching can help reverse scarring of the heart muscle (myocardial fibrosis) and improve blood pressure in people with hypertensive heart disease. The trial will enroll 200 phy…
Matched conditions: MYOCARDIAL FIBROSIS
Phase: NA • Sponsor: National University of Singapore • Aim: Disease control
Last updated May 17, 2026 07:07 UTC
-
Can a common heart drug reverse scarring in stiff heart failure?
Disease control Not yet recruitingThis study looks at whether the drug sacubitril/valsartan can reduce scarring in the heart muscle of people with a type of heart failure called HFpEF (stiff heart). About 36 adults aged 50 and older will get either the study drug or a similar drug alone. Researchers will use MRI …
Matched conditions: MYOCARDIAL FIBROSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 17, 2026 06:52 UTC